These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 15558559)

  • 1. Smooth muscle tumors of uncertain malignant potential and leiomyosarcomas of the uterus: MR findings.
    Tanaka YO; Nishida M; Tsunoda H; Okamoto Y; Yoshikawa H
    J Magn Reson Imaging; 2004 Dec; 20(6):998-1007. PubMed ID: 15558559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
    Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
    J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ki-67 expression in patients with uterine leiomyomas, uterine smooth muscle tumors of uncertain malignant potential (STUMP) and uterine leiomyosarcomas (LMS).
    Mayerhofer K; Lozanov P; Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K
    Acta Obstet Gynecol Scand; 2004 Nov; 83(11):1085-8. PubMed ID: 15488127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential diagnosis of uterine smooth muscle tumors using diffusion-weighted imaging: correlations with the apparent diffusion coefficient and cell density.
    Tasaki A; Asatani MO; Umezu H; Kashima K; Enomoto T; Yoshimura N; Aoyama H
    Abdom Imaging; 2015 Aug; 40(6):1742-52. PubMed ID: 25526683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelioid smooth muscle tumors of the uterus do not express CD1a: a potential immunohistochemical adjunct in their distinction from uterine perivascular epithelioid cell tumors.
    Fadare O; Liang SX
    Ann Diagn Pathol; 2008 Dec; 12(6):401-5. PubMed ID: 18995203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinosarcoma of the uterus: MR findings.
    Tanaka YO; Tsunoda H; Minami R; Yoshikawa H; Minami M
    J Magn Reson Imaging; 2008 Aug; 28(2):434-9. PubMed ID: 18666176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uterine smooth muscle tumors other than the ordinary leiomyomas and leiomyosarcomas: a review of selected variants with emphasis on recent advances and unusual morphology that may cause concern for malignancy.
    Ip PP; Tse KY; Tam KF
    Adv Anat Pathol; 2010 Mar; 17(2):91-112. PubMed ID: 20179432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic criteria for uterine smooth muscle tumors: leiomyoma variants associated with malignant behavior.
    Giuntoli RL; Gostout BS; DiMarco CS; Metzinger DS; Keeney GL
    J Reprod Med; 2007 Nov; 52(11):1001-10. PubMed ID: 18161397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathologic considerations of uterine smooth muscle tumors.
    Prayson RA; Hart WR
    Obstet Gynecol Clin North Am; 1995 Dec; 22(4):637-57. PubMed ID: 8786875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P16, Ki67, P53, and WT1 Expression in Uterine Smooth Muscle Tumors: An Adjunct in Confirming the Diagnosis of Malignancy in Ambiguous Cases.
    Delgado B; Dreiher J; Braiman D; Meirovitz M; Shaco-Levy R
    Int J Gynecol Pathol; 2021 May; 40(3):257-262. PubMed ID: 32897968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uterine smooth muscle tumours with hyperintense area on T
    Ando T; Kato H; Furui T; Morishige KI; Goshima S; Matsuo M
    Br J Radiol; 2018 Apr; 91(1084):20170767. PubMed ID: 29308922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging of typical polypoid adenomyoma of the uterus in 8 patients: correlation with pathological findings.
    Kitajima K; Imanaka K; Kuwata Y; Hashimoto K; Sugimura K
    J Comput Assist Tomogr; 2007; 31(3):463-8. PubMed ID: 17538297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Foci of decreased signal on T2-weighted MR images in leiomyosarcomas of soft tissue: correlation between MR and histological findings.
    Pilavaki M; Drevelegas A; Nenopoulou H; Scordalaki A; Chourmouzi D; Sofroniadis I; Dimitriadis AS
    Eur J Radiol; 2004 Sep; 51(3):279-85. PubMed ID: 15294338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative MR texture analysis for the differentiation of uterine smooth muscle tumors with high signal intensity on T2-weighted imaging.
    Kumagai K; Yagi T; Yamazaki M; Tasaki A; Asatani M; Ishikawa H
    Medicine (Baltimore); 2023 Aug; 102(31):e34452. PubMed ID: 37543807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine leiomyoma: correlation between signal intensity on magnetic resonance imaging and pathologic characteristics.
    Swe TT; Onitsuka H; Kawamoto K; Ueyama T; Tsuruchi N; Masuda K
    Radiat Med; 1992; 10(6):235-42. PubMed ID: 1287735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uterine smooth muscle tumors of uncertain malignant potential: diagnostic challenges and therapeutic dilemmas. Report of 2 cases and review of the literature.
    Vilos GA; Marks J; Ettler HC; Vilos AG; Prefontaine M; Abu-Rafea B
    J Minim Invasive Gynecol; 2012; 19(3):288-95. PubMed ID: 22546421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of dynamic enhanced magnetic resonance imaging for distinguishing between ovarian fibroma and subserous uterine leiomyoma.
    Thomassin-Naggara I; Daraï E; Nassar-Slaba J; Cortez A; Marsault C; Bazot M
    J Comput Assist Tomogr; 2007; 31(2):236-42. PubMed ID: 17414760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An immunohistochemical analysis of stathmin 1 expression in uterine smooth muscle tumors: differential expression in leiomyosarcomas and leiomyomas.
    Allen MM; Douds JJ; Liang SX; Desouki MM; Parkash V; Fadare O
    Int J Clin Exp Pathol; 2015; 8(3):2795-801. PubMed ID: 26045786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoexpression of p53 in cutaneous and subcutaneous leiomyosarcomas.
    Fernandez-Flores A; Monteagudo C
    Ann Diagn Pathol; 2016 Oct; 24():25-9. PubMed ID: 27649950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uterine leiomyosarcomas are characterized by high p16, p53 and MIB1 expression in comparison with usual leiomyomas, leiomyoma variants and smooth muscle tumours of uncertain malignant potential.
    O'Neill CJ; McBride HA; Connolly LE; McCluggage WG
    Histopathology; 2007 Jun; 50(7):851-8. PubMed ID: 17543074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.